Bladder Cancer Therapeutics MarketBladder Cancer Therapeutics Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2024

BLADDER CANCER THERAPEUTICS
MARKET
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2016–2024
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Bladder Cancer Therapeutics Market Overview
As per stats released by the World Cancer Research Fund International, around 430,000 new
cases of bladder cancer were diagnosed in 2012, with bladder cancer being the ninth-most
common cancer. The bladder holds urine before it leaves the body during urination. The disease
in which cancerous cells form in the tissues of the bladder is known as bladder cancer. There are
three major types of bladder cancer and are named on the basis of type of cells become
cancerous (malignant). These type are as follows –
• Transitional Cell Carcinoma: Transitional cell carcinoma is also called as urothelial carcinoma.
It begins in the urothelial cells of the bladder which are located in the lining the bladder. This
is the common type of bladder cancer.
Request Sample Copy of the Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/239
• Squamous Cell Carcinoma: This type of cancer initiates in the squamous cells and it develops
in the bladder, following prolonged irritation or infection
• Adenocarcinoma: This type of cancer begins in the secretory cells (glandular) that are located
in the lining of bladder. This is very rare type of bladder cancer.
According to the study of American Society of Clinical Oncology (ASCO), urothelial carcinoma
accounts for around 90%, squamous cell carcinoma accounts 4% and adenocarcinoma accounts
2% of all bladder cancer. The remaining 4% bladder cancer includes other rare type of bladder
cancer viz. sarcoma and small cell anaplastic cancer.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Increasing incidence rate, especially in developed regions fueling growth of bladder cancer
therapeutics market
As per stats released by the International Agency for Research on Cancer (IARC), 59% of bladder cancer
cases are observed in developed countries, with Belgium reporting the highest number of bladder
cancer cases.
As per stats released by Cancer Research UK—a charity involved in cancer research and development—
here were around 10,100 new cases reported in the U.K. in 2014. Bladder cancer accounts for around
3% of all new cancer cases reported in the U.K. As per a study by the American Society of Clinical
Oncology (ASCO), incidence rate of the disease has decreased by around 12% in the U.K. in the recent
past.
According a study by Cancer Research Institute, bladder cancer is more prevalent among men than
women. Around 77,000 new cases were diagnosed in the U.S. in 2016, leading to 16,000 deaths.
Continuous advancements in clinical research resulted into increased survival rate of people suffering
from bladder cancer, which is around 77% observed in last few years. As per the stats of American
Cancer Society, bladder cancer accounts for 5% of all new cancer cases in the U.S.
Some are the major reasons behind bladder cancer are unhealthy habits. Smoking is a major cause
along with that continuous exposure of industrial chemicals, drinking water with high level of arsenic,
family history of bladder cancer, and long-term use of urinary catheters are the other causes of bladder
cancer. In Africa and Middle East schistosomiasis and infested water are the leading cause of bladder
cancer.
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/239
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
North America holds major share in the global bladder cancer therapeutics market, followed by
Europe due to advanced treatments, developed economy, and easy access to advanced
healthcare facilities. The market in APAC region will witness high growth rate in the near future,
due to increasing per capita income, developing economy, government initiatives on improving
healthcare infrastructure, growing FDI in healthcare, and rapidly increasing aging population. As
per stats released by the Department of Industrial Policy and Promotion (DIPP), the healthcare
sector in India witness FDI worth US$ 4.09 billion between April 2000 and September 2016.
Also, medical tourism in the region is a flourishing business, due to easy access to high-quality
low-cost treatment option. According to data released by the India Brand Equity Foundation
(IBEF)— a Trust established by the Department of Commerce, Ministry of Commerce and
Industry, Government of India—the medical tourism industry in India rakes in US$ 3 billion
each year. This creates a highly conducive environment for growth of the bladder cancer
therapeutics market in the region.
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/239
The major companies playing key role in bladder therapeutics market are Sanofi S.A., F.
Hoffmann-La Roche AG, Novartis, Pfizer, Eli Lilly and Co., GlaxoSmithKline, Bristol-Myers
Squibb, Allergan Inc, AVI Biopharma Inc., and AstraZeneca plc. Some are the major drugs
approved by Food and Drug Administration used for the treatment of bladder cancer are
Cisplatin, Nivolumab, Thiotepa, Atezolizumab, Doxorubicin Hydrochloride, Opdivo
(Nivolumab), Platinol-AQ (Cisplatin), Platinol (Cisplatin), and Tecentriq (Atezolizumab).
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

As per stats released by the World Cancer Research Fund International, around 430,000 new cases of bladder cancer were diagnosed in 2012, with bladder cancer being the ninth-most common cancer. The bladder holds urine before it leaves the body during urination. The disease in which cancerous cells form in the tissues of the bladder is known as bladder cancer. There are three major types of bladder cancer and are named on the basis of type of cells become cancerous (malignant). These type are as follows –